These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuroblastoma in adolescents: the Italian experience. Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209 [TBL] [Abstract][Full Text] [Related]
3. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154 [TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification. Laprie A; Michon J; Hartmann O; Munzer C; Leclair MD; Coze C; Valteau-Couanet D; Plantaz D; Carrie C; Habrand JL; Bergeron C; Chastagner P; Défachelles AS; Delattre O; Combaret V; Bénard J; Pérel Y; Gandemer V; Rubie H; Cancer; 2004 Sep; 101(5):1081-9. PubMed ID: 15329919 [TBL] [Abstract][Full Text] [Related]
5. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies. van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181 [TBL] [Abstract][Full Text] [Related]
6. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification. Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726 [TBL] [Abstract][Full Text] [Related]
7. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152 [TBL] [Abstract][Full Text] [Related]
8. [Neuroblastoma at the Giannina Gaslini Institute. Analysis of 94 cases diagnosed 1972-1981]. De Bernardi B; Garaventa A; Bartolini M; Rizzo A; Rosanda C; Bisogni C; Melodia A; Magnaguagno G; Ricci G; Lamedica G Pediatr Med Chir; 1983; 5(1-2):49-58. PubMed ID: 6634442 [TBL] [Abstract][Full Text] [Related]
9. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry. Haupt R; Garaventa A; Gambini C; Parodi S; Cangemi G; Casale F; Viscardi E; Bianchi M; Prete A; Jenkner A; Luksch R; Di Cataldo A; Favre C; D'Angelo P; Zanazzo GA; Arcamone G; Izzi GC; Gigliotti AR; Pastore G; De Bernardi B J Clin Oncol; 2010 May; 28(14):2331-8. PubMed ID: 20351331 [TBL] [Abstract][Full Text] [Related]
10. Pattern and outcome of neuroblastoma. A 10 year study. Kusumakumary P; Ajithkumar TV; Ratheesan K; Chellam VG; Nair MK Indian Pediatr; 1998 Mar; 35(3):223-9. PubMed ID: 9707875 [TBL] [Abstract][Full Text] [Related]
11. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease. Simon T; Hero B; Bongartz R; Schmidt M; Müller RP; Berthold F Strahlenther Onkol; 2006 Jul; 182(7):389-94. PubMed ID: 16826357 [TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma in adults: Incidence and survival analysis based on SEER data. Esiashvili N; Goodman M; Ward K; Marcus RB; Johnstone PA Pediatr Blood Cancer; 2007 Jul; 49(1):41-6. PubMed ID: 16628557 [TBL] [Abstract][Full Text] [Related]
14. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma. Cheung NK; Guo HF; Heller G; Cheung IY Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706 [TBL] [Abstract][Full Text] [Related]
15. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival. Ozyar E; Gurkaynak M; Yildiz F; Atahan IL Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877 [TBL] [Abstract][Full Text] [Related]
16. [Can intensive induction chemotherapy eradicate retroperitoneal lymph node metastases in children over 1 year of age with stage 4 neuroblastoma?]. Niezgoda A; Balwierz W; Bysiek A; Miezyński W; Klekawka T; Garus K Przegl Lek; 2004; 61 Suppl 2():9-13. PubMed ID: 15686039 [TBL] [Abstract][Full Text] [Related]
17. Presenting features and treatment outcome of 78 Malaysian children with neuroblastoma. Ng SM; Abdullah WA; Lin HP; Chan LL Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):149-53. PubMed ID: 10695803 [TBL] [Abstract][Full Text] [Related]
18. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center. Mora J; Filippa DA; Qin J; Wollner N Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853 [TBL] [Abstract][Full Text] [Related]
19. Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92). Pillon M; Di Tullio MT; Garaventa A; Cesaro S; Putti MC; Favre C; Lippi A; Surico G; Di Cataldo A; D'Amore E; Zanesco L; Rosolen A Cancer; 2004 Jul; 101(2):385-94. PubMed ID: 15241838 [TBL] [Abstract][Full Text] [Related]
20. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study. McMeekin DS; Filiaci VL; Thigpen JT; Gallion HH; Fleming GF; Rodgers WH; Gynecol Oncol; 2007 Jul; 106(1):16-22. PubMed ID: 17574073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]